Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Enpro | NPO | Nov 1, 2024 | 147.32 | +1.17 |
Enservco | ENSV | Nov 1, 2024 | 0.15 | +0.14 |
Enstar Group | ESGR | Nov 1, 2024 | 321.74 | -0.24 |
Enstar Group Depository E Pref | ESGRO | Nov 1, 2024 | 20.74 | -1.42 |
Enstar Pref | ESGRP | Nov 1, 2024 | 21.19 | -0.94 |
Ensysce Biosciences | ENSC | Nov 1, 2024 | 0.65 | +12.85 |
Entegris | ENTG | Nov 1, 2024 | 107.05 | +2.23 |
Entera Bio | ENTX | Nov 1, 2024 | 1.80 | -0.55 |
Entergy | ETR | Nov 1, 2024 | 144.79 | -6.45 |
Entergy Texas A Pref | ETI- | Nov 1, 2024 | 24.25 | -0.14 |
Entergy Utility Enterprises | EMP | Nov 1, 2024 | 22.47 | -1.06 |
Entero Therapeutics | ENTO | Nov 1, 2024 | 0.69 | +7.50 |
Enterprise Bancorp | EBTC | Nov 1, 2024 | 32.07 | -0.12 |
Enterprise Financial Services | EFSC | Nov 1, 2024 | 52.69 | -0.06 |
Enterprise Financial Services A Pref | EFSCP | Nov 1, 2024 | 20.52 | +0.34 |
Enterprise Products Partners LP Unit | EPD | Nov 1, 2024 | 28.82 | +0.56 |
Entrada Therapeutics | TRDA | Nov 1, 2024 | 17.60 | +2.68 |
Entravision Communications | EVC | Nov 1, 2024 | 2.28 | -1.72 |
Envela | ELA | Nov 1, 2024 | 5.22 | -0.76 |
Enveric Biosciences | ENVB | Nov 1, 2024 | 0.49 | -1.50 |
Envestnet | ENV | Nov 1, 2024 | 62.82 | +0.06 |
Enviri | NVRI | Nov 1, 2024 | 7.27 | -5.09 |
Environmental Svcs ETF Market Vectors | EVX | Nov 1, 2024 | 181.23 | -0.02 |
Envirotech Vehicles | EVTV | Nov 1, 2024 | 1.85 | +1.65 |
Envista | NVST | Nov 1, 2024 | 20.94 | -0.14 |
Enviva | EVA | Nov 1, 2024 | 0.42 | 0.00 |
Envoy Medical A | COCH | Nov 1, 2024 | 2.55 | -3.77 |
enVVeno Medical | NVNO | Nov 1, 2024 | 3.35 | -0.59 |
Enzo Biochem | ENZ | Nov 1, 2024 | 1.13 | -1.74 |
EOG Resources | EOG | Nov 1, 2024 | 120.84 | -0.92 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.